BSX vs CDW · P/E 20, rev $16.75B vs P/E 22, rev $21.00B
Boston Scientific Corp (BSX) versus CDW Corp (CDW) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
CDW Corp (CDW) is a information technology services company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported CDW revenue for 2024-12-31 was $21.00B. Net income was $1.08B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
Not investment advice. Open the BSX and CDW stock pages for the full models.
Not investment advice.